CervoMed
CRVO
45 hedge funds and large institutions have $17.3M invested in CervoMed in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 12 closing their positions.
26% more capital invested
Capital invested by funds: $13.7M → $17.3M (+$3.59M)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding
Funds holding: 45 → 45 (0)
1.92% less ownership
Funds ownership: 24.97% → 23.05% (-1.9%)
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$332K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$262K |
| 3 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$235K |
| 4 |
SAI
Savvy Advisors Inc
New York
|
+$222K |
| 5 |
HCM
Hilton Capital Management
Garden City,
New York
|
+$149K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$474K |
| 2 |
Jane Street
New York
|
-$414K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$143K |
| 4 |
Goldman Sachs
New York
|
-$133K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$82.2K |
CRVO Hedge Fund Activity: Q3 2025 in Review
45 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2025, worth a combined $17.3M — up 26% from $13.7M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CRVO positions and 12 closed out — a net gain of 1 holder — while 7 added to existing stakes and 16 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $332K. The largest seller was BlackRock, cutting an estimated $474K.
- 45 institutional investors held CervoMed (CRVO) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $17.3M of CervoMed stock for Q3 2025, up 26% quarter-over-quarter.
- 13 funds opened new CervoMed positions in Q3 2025 and 12 closed out, a net change of +1 holder.
- The largest CervoMed buyer in Q3 2025 was Morgan Stanley, an estimated $332K added.
- The largest CervoMed seller in Q3 2025 was BlackRock, an estimated $474K sold.
Based on aggregated 13F filings for Q3 2025.